Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development --- --- John Adams, PhD Appointed Chief ...
Inhibikase Therapeutics (IKT) announced the appointment of two pharma industry executives to its senior leadership team. Chris Cabell, M.D., ...
After hours: 7:41:16 p.m. EST ...
Inhibikase's multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program risvodetinib, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's ...
The NIH has lost two distinguished leaders as mass layoffs directed by the Trump administration hit federal health agencies.
Recursion will host a (L)earnings Call on February 28, 2025 at 8:30 am ET / 6:30 am MT / 1:30 pm GMT. The company will broadcast the live stream from Recursion's X (formerly Twitter), LinkedIn, and ...
After hours: February 21 at 4:41:55 PM EST Loading Chart for NMTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results